216 related articles for article (PubMed ID: 33726652)
1. Drug Repositioning: A Unique Approach to Refurbish Drug Discovery.
Kale MA; Shamkuwar PB; Mourya VK; Deshpande AB; Shelke PA
Curr Drug Discov Technol; 2022; 19(1):e140122192307. PubMed ID: 33726652
[TBL] [Abstract][Full Text] [Related]
2. Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery.
Roy S; Dhaneshwar S; Bhasin B
Curr Drug Res Rev; 2021; 13(2):101-119. PubMed ID: 33573567
[TBL] [Abstract][Full Text] [Related]
3. Drug repositioning: re-investigating existing drugs for new therapeutic indications.
Padhy BM; Gupta YK
J Postgrad Med; 2011; 57(2):153-60. PubMed ID: 21654146
[TBL] [Abstract][Full Text] [Related]
4. A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery.
Pillaiyar T; Meenakshisundaram S; Manickam M; Sankaranarayanan M
Eur J Med Chem; 2020 Jun; 195():112275. PubMed ID: 32283298
[TBL] [Abstract][Full Text] [Related]
5. Computational Drug Repositioning: A Lateral Approach to Traditional Drug Discovery?
Sahu NU; Kharkar PS
Curr Top Med Chem; 2016; 16(19):2069-77. PubMed ID: 26881717
[TBL] [Abstract][Full Text] [Related]
6. A review of validation strategies for computational drug repositioning.
Brown AS; Patel CJ
Brief Bioinform; 2018 Jan; 19(1):174-177. PubMed ID: 27881429
[TBL] [Abstract][Full Text] [Related]
7. A systems-level analysis of drug-target-disease associations for drug repositioning.
Rutherford KD; Mazandu GK; Mulder NJ
Brief Funct Genomics; 2018 Jan; 17(1):34-41. PubMed ID: 28968683
[TBL] [Abstract][Full Text] [Related]
8. Predicting new indications for approved drugs using a proteochemometric method.
Dakshanamurthy S; Issa NT; Assefnia S; Seshasayee A; Peters OJ; Madhavan S; Uren A; Brown ML; Byers SW
J Med Chem; 2012 Aug; 55(15):6832-48. PubMed ID: 22780961
[TBL] [Abstract][Full Text] [Related]
9. Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning.
Shameer K; Glicksberg BS; Hodos R; Johnson KW; Badgeley MA; Readhead B; Tomlinson MS; O'Connor T; Miotto R; Kidd BA; Chen R; Ma'ayan A; Dudley JT
Brief Bioinform; 2018 Jul; 19(4):656-678. PubMed ID: 28200013
[TBL] [Abstract][Full Text] [Related]
10. In silico drug repositioning: from large-scale transcriptome data to therapeutics.
Kwon OS; Kim W; Cha HJ; Lee H
Arch Pharm Res; 2019 Oct; 42(10):879-889. PubMed ID: 31482491
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel analgesics through a drug repurposing strategy.
Gazerani P
Pain Manag; 2019 Jul; 9(4):399-415. PubMed ID: 30950770
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
Turanli B; Gulfidan G; Arga KY
OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
[TBL] [Abstract][Full Text] [Related]
13. A Review of Recent Developments and Progress in Computational Drug Repositioning.
Shi W; Chen X; Deng L
Curr Pharm Des; 2020; 26(26):3059-3068. PubMed ID: 31951162
[TBL] [Abstract][Full Text] [Related]
14. Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
Luo H; Wang J; Li M; Luo J; Ni P; Zhao K; Wu FX; Pan Y
IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1890-1900. PubMed ID: 29994051
[TBL] [Abstract][Full Text] [Related]
15. Computational and Practical Aspects of Drug Repositioning.
Oprea TI; Overington JP
Assay Drug Dev Technol; 2015; 13(6):299-306. PubMed ID: 26241209
[TBL] [Abstract][Full Text] [Related]
16. In silico repositioning of approved drugs for rare and neglected diseases.
Ekins S; Williams AJ; Krasowski MD; Freundlich JS
Drug Discov Today; 2011 Apr; 16(7-8):298-310. PubMed ID: 21376136
[TBL] [Abstract][Full Text] [Related]
17. MeSHDD: Literature-based drug-drug similarity for drug repositioning.
Brown AS; Patel CJ
J Am Med Inform Assoc; 2017 May; 24(3):614-618. PubMed ID: 27678460
[TBL] [Abstract][Full Text] [Related]
18. Drug repositioning: Progress and challenges in drug discovery for various diseases.
Hua Y; Dai X; Xu Y; Xing G; Liu H; Lu T; Chen Y; Zhang Y
Eur J Med Chem; 2022 Apr; 234():114239. PubMed ID: 35290843
[TBL] [Abstract][Full Text] [Related]
19. In silico drug repositioning: what we need to know.
Liu Z; Fang H; Reagan K; Xu X; Mendrick DL; Slikker W; Tong W
Drug Discov Today; 2013 Feb; 18(3-4):110-5. PubMed ID: 22935104
[TBL] [Abstract][Full Text] [Related]
20. Anticancer Drug Discovery By Structure-Based Repositioning Approach.
Modh DH; Kulkarni VM
Mini Rev Med Chem; 2024; 24(1):60-91. PubMed ID: 37165589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
